This article is published by Prometheuz Health, a men's health telehealth provider. Prometheuz offers FDA-approved TRT evaluation and prescriptions through a licensed, LegitScript-certified process. It reflects the commercial interests of the publisher. Content is for educational purposes only. It does not replace evaluation by your own licensed healthcare provider.
Quick answer: Sermorelin is a growth hormone-releasing hormone (GHRH) analog that signals your pituitary to release more of your own growth hormone. The original branded version was FDA-approved, but only for pediatric growth hormone deficiency. Adult use today is compounded and prescribed off-label. Moreover, evidence for adult benefits is limited, and compounding rules for this peptide class are still evolving, so you must confirm current status with your provider.
What Is Sermorelin?
Sermorelin is a synthetic peptide made of the first 29 amino acids of human growth hormone-releasing hormone (GHRH). It's short enough to be classified as a peptide, not a full protein, but long enough to bind the same pituitary receptor as natural GHRH.
GHRH receptor. This is the docking site on pituitary cells that, once triggered, tells the pituitary to release growth hormone (GH) in a pulse.
Because sermorelin stimulates your own GH release rather than replacing GH outright, it produces a pulsatile pattern closer to how your body naturally releases growth hormone.
The Original FDA Approval Was Narrow, and Discontinued for Business Reasons
The FDA approved sermorelin, under the brand name Geref, in 1990 for diagnosing growth hormone deficiency and in 1997 for treating idiopathic growth hormone deficiency in children with growth failure. The manufacturer voluntarily discontinued Geref in 2008. The FDA later confirmed in a 2013 Federal Register determination that the withdrawal was not due to safety or effectiveness concerns.
Sermorelin prescribed for adults today is compounded through a licensed 503A pharmacy and prescribed off-label. It is not FDA-approved for adult use, including body composition, recovery, or anti-aging goals.
Compounding rules for growth hormone-releasing peptides as a category are an area of active regulatory discussion. Rather than rely on a fixed rule stated here, ask your provider about sermorelin's current regulatory status before starting, since this landscape can shift.
How Does Sermorelin Work in the Body?
Sermorelin binds GHRH receptors on pituitary cells called somatotrophs, prompting them to release a pulse of growth hormone. It has a short plasma half-life, around 11 to 12 minutes, so its effect is brief and self-limiting rather than continuous.
This matters because it preserves your body's natural feedback loop. Growth hormone released this way still triggers the same downstream regulation that keeps GH from building up unchecked, unlike a fixed dose of synthetic HGH delivered directly.
What Are the Potential Benefits of Sermorelin?
Evidence for sermorelin is strongest in its original pediatric indication. Evidence for clinical benefits in adults is limited, particularly for wellness, anti-aging, sleep, recovery, and body-composition claims. Sermorelin's mechanism plausibly connects to these areas, but mechanism is not the same as a demonstrated patient benefit:
- Body composition. Growth hormone plays a role in regulating lean mass and fat metabolism, but adult sermorelin-specific trial data establishing a body-composition benefit is limited.
- Sleep-linked GH release. Most natural growth hormone release happens during deep sleep, which is part of why sermorelin is often taken at bedtime, though this doesn't establish a proven sleep benefit from sermorelin itself.
These are potential, mechanism-based areas of interest, not established or guaranteed outcomes. Off-label adult use hasn't gone through the same clinical trial process as the original pediatric approval.
How Is Sermorelin Dosed and Administered?
Sermorelin is given as a subcutaneous injection. Dosing and administration timing depend on the specific indication, formulation, and clinician-directed protocol - compounded adult protocols can vary, so there isn't one single standard regimen the way there was for the original approved pediatric product.
Dosage isn't one-size-fits-all. A licensed clinician sets it based on your labs, health history, and response over time, then adjusts at follow-up visits rather than locking in a fixed amount from day one.
Some clinics combine sermorelin with other growth hormone-releasing peptides, like GHRP-2 or GHRP-6, to intensify the signal. The clinical efficacy and long-term safety of this combination approach have not been established in adequate trials, so it should only be considered under direct specialist supervision, not as a default add-on.
What Are the Side Effects of Sermorelin?
Commonly reported effects include:
- Injection site redness, swelling, or discomfort
- Facial flushing shortly after injection
- Headache or mild dizziness
- Water retention in some patients
This isn't an exhaustive list, and it doesn't mean sermorelin is risk-free, which is why ongoing monitoring is part of every plan.
What Results Can You Expect, and When?
The timing and magnitude of clinical response to sermorelin in adults are not well established. Unlike its original pediatric indication, where growth response was measured in controlled trials, adult off-label use doesn't have a comparable evidence base for predicting when, or whether, a given effect will appear.
Quarterly monitoring exists specifically because individual response varies, and a clinician needs real data, not a fixed timeline, to know whether a protocol is working.
Sermorelin vs. Direct HGH Therapy
| Sermorelin | Direct HGH (Synthetic Growth Hormone) | |
|---|---|---|
| Mechanism | Signals pituitary to release your own GH | Supplies growth hormone directly |
| Release pattern | Pulsatile, closer to natural rhythm | Continuous, fixed dose |
| FDA status (adult use) | Not approved; compounded, off-label | Approved only for specific diagnosed conditions |
| Feedback loop | Preserved | Bypassed |
| Typical side effects | Injection site flushing, redness | Joint pain, fluid retention, insulin sensitivity changes |
Neither option is inherently "better" for every patient. The right choice depends on labs, goals, and a licensed clinician's review, which is exactly why sermorelin isn't offered without an intake process.
Who Can Get Sermorelin?
Sermorelin at Prometheuz is available to patients aged 25 and older only, based on clinical intake protocol. Beyond the age cutoff, candidacy is determined by a clinician through health history, examination, and appropriate endocrine evaluation, not by symptoms alone. Relevant factors a clinician may weigh include:
- Labs consistent with reduced growth hormone signaling. An abnormal IGF-1 result may prompt further evaluation, but IGF-1 alone does not establish adult growth hormone deficiency.
- A documented medical history and examination consistent with a recognized indication, not just nonspecific complaints like fatigue or poor sleep in isolation
- No pregnancy, active cancer, or medications that interact with GH signaling
Final eligibility always depends on your full health history and a licensed clinician's review, since sermorelin isn't appropriate for everyone.
Who Should Be Cautious or Avoid It
A clinician may advise against sermorelin for patients who are pregnant, have active cancer, have certain pituitary conditions, or are on medications that interact with growth hormone signaling. This is why lab review and clinician sign-off come before any prescription, not after.
What Does Sermorelin Cost?
Sermorelin is billed monthly, cash-pay, with lower per-month pricing the further out you commit.
| Plan | Price | Billed As | Total Savings |
|---|---|---|---|
| Monthly (4-week) | $229/mo | $229 | - |
| 3-Month Plan | $179/mo | $537 | Save $150 |
| 6-Month Plan | $159/mo | $954 | Save $420 |
| 52-Week Plan | $149/mo | $1,937 | Save $1,040 |
Included in every plan: US-licensed clinician review, a personalized peptide protocol, medication management, secure care messaging, follow-up support, and quarterly monitoring.
Sermorelin is compounded by a licensed 503A pharmacy per individual prescription. It is not FDA-approved for adult use, and not all patients will qualify.
Start With a Licensed Review, Not a Guess
Given the age cutoff, the health screening involved, and a regulatory picture that's still shifting, sermorelin isn't something to start based on a marketing page alone. Prometheuz starts with your labs and health history, so a licensed clinician can confirm whether sermorelin actually fits your situation before anything ships.
Frequently Asked Questions
Is sermorelin the same as HGH?
No. Sermorelin signals your pituitary gland to release your own growth hormone. HGH therapy supplies synthetic growth hormone directly.
Is sermorelin FDA-approved?
The original branded version was FDA-approved, but only for diagnosing and treating growth hormone deficiency in children. Adult use today is compounded and prescribed off-label.
How is sermorelin taken?
Sermorelin is given as a subcutaneous injection. Timing and frequency depend on your clinician's specific protocol rather than one fixed standard regimen.
Who is sermorelin not appropriate for?
Sermorelin may not be appropriate for patients who are pregnant, have active cancer, have certain pituitary conditions, or take medications that interact with growth hormone signaling. A clinician reviews this before prescribing.
How long before I'd notice a difference?
The timing and magnitude of clinical response in adults are not well established. Your clinician uses quarterly monitoring and labs, not a fixed timeline, to assess whether a protocol is working for you.
Why is sermorelin only available to patients 25 and older?
Prometheuz uses a minimum age of 25 as part of its clinical intake protocol. This is a company policy, not an FDA-established sermorelin age requirement.
Disclaimer
This content is for educational purposes only and does not replace medical advice. Sermorelin is not FDA-approved for adult use. It is compounded by a licensed 503A pharmacy and prescribed off-label at the sole discretion of a licensed clinician following an individualized review. Not all patients will qualify.
References
U.S. Food and Drug Administration. Determination that GEREF (Sermorelin Acetate) Injection was not withdrawn from sale for reasons of safety or effectiveness. Federal Register. 2013. https://www.federalregister.gov/documents/2013/03/04/2013-04827/determination-that-geref-sermorelin-acetate-injection-05-milligrams-basevial-and-10-milligrams
U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Medical Review(s) referencing Geref Diagnostic (sermorelin acetate) approval history. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022505Orig1s000MedR.pdf
